Abstract
Cytoprotection has been defined as the ability of pharmacological agents to prevent or reduce gastric, duodenal, or intestinal mucosal injury produced by a variety of agents without affecting intragastric acidity. Prostaglandins (PGs) have been shown to protect the gastric mucosa against (a) ulcerogenic insults by aspirin, indomethacin, bile acids, serotonin, and restraint, and (b) damage produced by necrotizing agents such as absolute alcohol, boiling water, 0.6 N HCl, 0.2 N NaOH, and overdistention (Robert at al. 1979, 1984; Tarnawski 1980; Miller 1983; Marti-Bonmati et al. 1980). A demonstration of cytoprotection is the oral or subcutaneous pretreatment of experimental animals (Robert et al. 1979, 1884; Tarnawski 1980) with a small amount of synthetic or natural PGs prior to the insult, which significantly reduces or even completely prevents mucosal necrosis after exposure to absolute alcohol, boiling water, or other noxious factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bakhle YS (1983) Synthesis and catabolism of cyclo-oxygenase products. Br Med Bull 39:214–218.
Chow SL, Hollander D (1978) Arachidonic acid intestinal absorption: Mechanism of transport and influence of luminal factors on absorption in vitro, Lipids 11:768–776.
Chow SL, Hollander D (1979a) Linoleic acid absorption in the unanesthetized rat: mechanism of transport and influence of luminal factors on absorption rate. Lipids 14:378–385.
Chow SL, Hollander D (1979b) A dual, concentration-dependent absorption mechanism of linoleic acid by rat jejunum in vitro. J Lipid Res 20:349–356.
Gali C, Agrandi E, Petroni A, Tremoli E (1980) Dietary essential fatty acid, tissue fatty acids and Prostaglandin synthesis. Prog Fd Nutr Sci 4:1–7.
Grant HW, Palmer KR, Kelly RW, Wilson NH, Misiewicz JJ (1988) Dietary linoleic acid gastric acid and Prostaglandin secretion. Gastroenterology 94:955–959.
Hollander D, Tarnawski A (1986a) Dietary essential fatty acids and the decline in peptic ulcer disease — a hypothesis. Gut 27:239–242.
Hollander D, Tarnawski A (1986b) Dietary essential fatty acids and peptic ulcer disease (letter to the editor). Gut 27:1108–1109.
Hollander D, Tarnawski A, Ivey KJ, DeZeery A, Zipser RD, McKenzie WN (1982) Arachidonic acid protection of rat gastric mucosa against ethanol injury. J Lab Clin Med 100:296–308.
Hollander D, Dadufalza VD, Sletten EG (1984) Does essential fatty acid absorption change with aging? J Lipid Res 25:129–134.
Konturek JS, Pawlik W (1986) Physiology and pharmacology of Prostaglandins. Dig Dis Sci[Feb Suppl] 31:6s–19s.
Marti-Bonmati E, Alino SF, Loris JM et al. (1980) Effects of cimetidine, atropine and Prostaglandin E2 on rat mucosal erosions produced by intragastric distension. Eur J Pharmacol 68:48–53.
Miller T (1983) Protective effects of Prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 245:G601–23.
Nilsson A, Melin T (1988) Absorption and metabolism of orally fed arachidonic and linoleic acid in the rat. Am J Physiol 255:G612–618.
Rainford KD (1978) The role of aspirin in gastric ulceration. Some factors involved in the development of gastric mucosal damage induced by aspirin in rats exposed to various stress conditions. Am J Digest Dis 23:521–530.
Rainford KD, Fox SA, Osborne DJ (1984) Comparative effects of some non-steroidal antiinflammatory drugs on the ultrastructural integrity and Prostaglandin levels in the gastric mucosa. Relationship to drug uptake. Scand J Gastroenteroll (Suppl 101) 19:55–68.
Ramwell PW (1981) Biologic importance of arachidonic acid. Arch Int Med 141:275–278.
Redfern JS, Feldman M (1989) Role of endogenous Prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to Prostaglandins. Gastroenterology 96:596–605.
Redfern JS, Blair AJ, Lee E, Feldman M (1987) Gastrointestinal ulcer formation in rabbits immunized with Prostaglandin E2. Gastroenterology 93:744–752.
Rizek RL, Welsh SO, Marston RM (1984) Levels and sources of fat in the US food supply and in diets of individuals. In: Milner J, Perkins EG (eds) Cancer — a molecular event. American oil Chemists’ society.
Robert A, Nezamis JE, Lancaster C, Hanchar AJ (1979) Cytoprotection by Prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 77:433–443.
Robert A, Lancaster C, Davis JP et al. (1984) Distinction between antiulcer effect and cytoprotection. Scand J Gastroenterol (Suppl 101) 19:69–72.
Robins PG (1980) Ultrastructural observations on the pathogenesis of aspirin induced gastric erosions. Br J Exp Pathol 61:497–504.
Schepp W, Steffen B, Ruoff HJ, Schusdziarra V, Classen M (1988) Modulation of rat gastric mucosal Prostaglandin E2 release by dietary linoleic acid: effects on gastric acid secretion and stress-induced mucosal damage. Gastroenterology 95:18–25.
Szabo S, Trier JS, Brown A, Schnoor J (1985) Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 88:228.
Tarnawski A (1980) Cytoprotection. A new fashion or real progress? Pol Arch Med Weswn 64:97–104.
Tarnawski A, Hollander D, Stachura J, Krause WJ (1983) Arachidonic acid protection of gastric mucosa against alcohol injury: sequential analysis of morphologic and functional changes. J Lab Clin Med 102:340–351.
Tarnawski A, Hollander D, Stachura J et al. (1985a) Prostaglandin protection of the gastric mucosa against alcohol injury — dynamic time related process. The role of the mucosal proliferative zone. Gastroenterology 89:366–374.
Tarnawski A, Hollander D, Stachura J (1985b) Ultrastructural changes in the gastric mucosal microvessels after ethanol. Gastroenterol Clin Biol 9(12 bis):93–97.
Tarnawski A, Brzozowski T, Hollander et al. (1986a) Prostaglandin protection of isolated human gastric glands against ethanol-induced injury. Evidence for cytoprotection in vitro (abstract). Gastroenterology 90:1658.
Tarnawski A, Hollander D, Stachura J, Dadufalza V, Gergely H (1986b) Is arachidonic acid protected gastric mucosa more resistant to rechallenge with a second dose of ethanol? Klin Wochenschr 64:35–39.
Tarnawski A, Hollander D, Gergely H (1987) Protection of gastric mucosa by linoleic acid — a nutrient essential fatty acid. Clin Invest Med 10:132–136.
Tarnawski A, Hollander D, Stachura J, Gergely H (1988a) Essential fatty acids — arachidonic and linoleic have trophic and angiogenic effect on the gastric mucosa injured by alcohol. Gastroenterology 94:A455.
Tarnawski A, Stachura J, Gergely H, Hollander D (1988b) Microvascular endothelium — a major target for alcohol injury of the human gastric mucosa. Histochemical and ultrastructural study. J Clin Gastroenterol 10(1):554–564.
Tarnawski A, Hollander D, Stachura J, Krause WJ, Gergely H (1989a) Protection of the gastric mucosa against aspirin injury by arachidonic acid — a dietary Prostaglandin precursor fatty acid. Eur J Clin Invest 19:278–290.
Tarnawski A, Hollander D, Stachura J, Sarfeh IJ, Gergely H, Krause WJ (1989) Angiogenic response of gastric mucosa to ethanol injury is abolished by indomethacin. Gastroenterology 96:A505.
Vane JR, Moncada S (1979) Polyunsaturated fatty acids as precursors of prostaglandins. Acta Cardiol [Suppl] (Brux) 23:21–37.
Whittle BJR (1977) Mechanisms underlying gastric mucosal damage induced by indomethacin and bile salts and the actions of Prostaglandins. Br J Pharmacol 60:455–460.
Whittle BJR, Vane JR (1986) Prostanoids as regulators of gastrointestinal function. In: Johnson LR (ed) Physiology of the gastrointestinal tract, 2nd edn. Raven, New York, pp 147–180.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hollander, D., Tarnawski, A. (1991). The Role of Essential Fatty Acids in Gastric and Duodenal Protection and Ulcer Therapy. In: Collen, M.J., Benjamin, S.B. (eds) Pharmacology of Peptic Ulcer Disease. Handbook of Experimental Pharmacology, vol 99. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75858-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-75858-4_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-75860-7
Online ISBN: 978-3-642-75858-4
eBook Packages: Springer Book Archive